Cogent BiosciencesCOGT
那斯達克 · USD
40.04
+0.87
(+2.22%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Cogent BiosciencesCOGT
40.04
+0.87
(+2.22%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 83,355 | 75,582 | - | - | - | - | - | 58,228 | 59,580 | 47,085 |
研發費用 | 68,989 | 62,203 | 63,029 | 62,045 | 63,614 | 54,294 | 52,705 | 48,719 | 50,127 | 38,871 |
推銷及管理費用 | 14,366 | 13,379 | 11,904 | 11,689 | 11,800 | 10,093 | 9,699 | 9,509 | 9,453 | 8,214 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -83,355 | -75,582 | -74,933 | -73,734 | -75,414 | -64,387 | -62,404 | -58,228 | -59,580 | -47,085 |
其他收入及費用 | 3,884 | 2,367 | 2,947 | 5,807 | 4,780 | 5,437 | 4,056 | 3,863 | 4,198 | 3,009 |
利息費用 | 1,459 | 314 | - | - | - | - | - | - | - | - |
稅前純益 | -80,930 | -73,529 | -71,986 | -67,927 | -70,634 | -58,950 | -58,348 | -54,365 | -55,382 | -44,076 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -80,930 | -73,529 | -71,986 | -67,927 | -70,634 | -58,950 | -58,348 | -54,365 | -55,382 | -44,076 |
基本每股稅後盈餘(元) | -0.58 | -0.65 | -0.63 | -0.61 | -0.52 | -0.43 | -0.49 | -0.63 | -0.64 | -0.59 |
稀釋每股稅後盈餘(元) | -0.50 | -0.53 | -0.52 | -0.50 | -0.53 | -0.42 | -0.49 | -0.15 | -0.65 | -0.59 |
基本平均股數(千股) | 139827.00 | 113928.00 | 113856.00 | 110461.00 | 110165.00 | 99240.00 | 94804.00 | 86730.00 | 86165.00 | 74753.00 |
稀釋平均股數(千股) | 139827.00 | 113928.00 | 113856.00 | 110461.00 | 110165.00 | 99240.00 | 94804.00 | 86730.00 | 86165.00 | 74753.00 |
還原基本每股稅後盈餘(元) | -0.58 | -0.65 | -0.63 | -0.61 | -0.52 | -0.43 | -0.49 | -0.63 | -0.64 | -0.59 |
還原稀釋每股稅後盈餘(元) | -0.50 | -0.53 | -0.52 | -0.50 | -0.53 | -0.42 | -0.49 | -0.15 | -0.65 | -0.59 |
還原基本平均股數(千股) | 139,827 | 113,928 | 113,856 | 110,461 | 110,165 | 99,240 | 94,804 | 86,730 | 86,165 | 74,753 |
還原稀釋平均股數(千股) | 139,827 | 113,928 | 113,856 | 110,461 | 110,165 | 99,240 | 94,804 | 86,730 | 86,165 | 74,753 |
EBITDA(千元) | -78,191 | -71,779 | -71,803 | -69,423 | -75,737 | -55,289 | -58,678 | -57,873 | -53,618 | -43,597 |